Our top pick for
Building a portfolio

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
AdaptHealth Corp is a medical devices business based in the US. AdaptHealth shares (AHCO) are listed on the NASDAQ and all prices are listed in US Dollars. AdaptHealth employs 4,700 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Building a portfolio
Our top pick for
Beginners
Our top pick for
Active traders
52-week range | $13.60 - $39.76 |
---|---|
50-day moving average | $34.76 |
200-day moving average | $33.00 |
Wall St. target price | $45.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.66 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing AdaptHealth stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AdaptHealth's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
AdaptHealth's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $171.8 million.
The EBITDA is a measure of a AdaptHealth's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $1.1 billion |
---|---|
Operating margin TTM | 8.52% |
Gross profit TTM | $191.3 million |
Return on assets TTM | 4.77% |
Return on equity TTM | -32.93% |
Profit margin | -6.1% |
Book value | N/A |
Market capitalisation | $3.3 billion |
TTM: trailing 12 months
There are currently 3.3 million AdaptHealth shares held short by investors – that's known as AdaptHealth's "short interest". This figure is 54.3% up from 2.1 million last month.
There are a few different ways that this level of interest in shorting AdaptHealth shares can be evaluated.
AdaptHealth's "short interest ratio" (SIR) is the quantity of AdaptHealth shares currently shorted divided by the average quantity of AdaptHealth shares traded daily (recently around 1.4 million). AdaptHealth's SIR currently stands at 2.25. In other words for every 100,000 AdaptHealth shares traded daily on the market, roughly 2250 shares are currently held short.
However AdaptHealth's short interest can also be evaluated against the total number of AdaptHealth shares, or, against the total number of tradable AdaptHealth shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AdaptHealth's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 AdaptHealth shares in existence, roughly 30 shares are currently held short) or 0.0402% of the tradable shares (for every 100,000 tradable AdaptHealth shares, roughly 40 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AdaptHealth.
Find out more about how you can short AdaptHealth stock.
We're not expecting AdaptHealth to pay a dividend over the next 12 months.
AdaptHealth Corp. , together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania. .
Everything we know about the Talaris Therapeutics IPO, plus information on how to buy in.
Everything we know about the Sagimet Biosciences IPO, plus information on how to buy in.
Everything we know about the Zenvia IPO, plus information on how to buy in.
Everything we know about the Grove IPO, plus information on how to buy in.
Everything we know about the Pasithea Therapeutics IPO, plus information on how to buy in.
Features, fees and complaints to consider before you apply for a T. Rowe Price account.
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.